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A total of 42 strains of actinobacteria were isolated from five different stations. Out of these 42 isolates, the suspected 10 
actinobacterial strains were screened and inoculated for purification, and based on the preliminary screening results, MAB18 
was taken to investigate the extraction evaluation of its antimicrobial property. Then it was tested against bacterial and 
fungal pathogens. The highest zone of inhibition was observed against E. coli (8.2±0.8mm), P. aeroginosa (10.4±0.6 mm), 
Vibrio harveyi (7.2±0.8mm), S. typhi (10.6±-0.4 mm) for bacteria and A. niger (11.2±0.8 mm), and A. flavus (9.8±0.2 mm) 
C. albicans (10.4±0.6mm), and Penicillium sp. (7.2±0.8mm), for fungi, whereas it was 21.4±0.6 and 20.4±0.6 mm for the 
standard ampicillin and nystatin. The antibiotic producing actinomycetes may be tapped as one of the India’s potential 
source of novel antibiotics to be used against both bacterial and fungal pathogenic organisms. 
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Introduction 
Marine microorganisms have become an important 
source of study for novel drug discovery. Recently, 
both researchers and industrialists have concentrated 
on marine microorganisms for novel products. Due to 
the climatic conditions of the marine environment, 
almost each group of marine organism exhibits 
diversity of molecules with unique structural features, 
which are not found in terrestrial natural products. 
Although, the marine environment contains much 
greater biodiversity than the terrestrial, the efforts to 
exploit the marine biodiversity by identifying new 
chemical compounds have hardly begun1. 
Actinobacteria are the most economical and 
biotechnologically valuable class of prokaryotes 
producing bioactive secondary metabolites notably 
antibiotics2 anti-tumor agents and immunosuppressive 
agents3 and enzymes4,5. Actinomycetes are the main 
source of clinically important antibiotics, besides 
vitamins and enzymes. The Streptomyces are 
especially prolific, producing around 80% of total 
antibiotic products6,7. The marine actinomycetes 
account for a major fraction of microbial metabolites 
and, among them, Streptomyces is the distant and 
most abundant genus. Antagonistic actinomycetes of 
marine origin are being regularly reported8,16. 
However, it soon became apparent during screening 
programmes that some microbial metabolites were 
discovered more frequently than others. Rare or novel 
actinomycete taxa have become a major focus in the 
search for pharmaceutical agents17.  
In pharmaceutical industry, over several decades, 
isolated and screened millions of Streptomyces 
strains. Consequently, the chances of isolating a novel 
Streptomyces strain have substantially diminished, 
and so has the probability of discovering a novel 
compound also less. Therefore, it has been estimated 
that only a fraction of the antibiotics produced by 
Streptomyces strains has been discovered18, and 
identifying the undiscovered portion will require a 
substantial effort. Consequently, a well-defined 
taxonomic study of actinobacteria is important to 
ascertain the correct species that produces novel 
secondary metabolites. Further, the discovery of novel 
antibiotic through screening of secondary metabolite 
is progressively more important.  
Hence, the present study was carried out to screen 
antagonistic marine actinobacteria isolated from near-
sea shore sediments along south-east coast of India. 
The potential antibiotic producing actinobacteria 
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strain was screened, identified and used for the 
investigation of antibacterial activity against different 
human clinical pathogens.  
 
Materials and Methods 
Isolation of actinobacteria 
The sediment samples were serially diluted and 
plated on Actinomycetes Isolation Agar medium 
supplemented with 20 mg/l of cycloheximide to 
eliminate fungal and bacterial contaminations19. The 
plates were incubated at 28±2 °C for 7-28 days. The 
actinobacteria colonies that appear on the petriplates 
were counted. All the experiments were carried out in 
triplicate. Further, the strains were sub-cultured and 
incubated at 28 °C for 2-4 weeks to isolate good 
sporulating actinobacteria and then the strains were 
stored in the deep freezer at -20 °C. Further, the 
actinobacterial strains were identified using 
conventional methods, such as morphological 
characteristics (Aerial mass colour, melanoid pigments, 
reverse side pigments, and soluble pigments), 
physiological characteristics (Assimilation of carbon 
sources and assimilation of nitrogen sources),  
chemotaxonomical analysis (Hydrolysis, thin layer 
chromatography, amino acids, whole-cell sugars), and 
micromorphological characteristics (Spore chain 
morphology). The strains were sub-cultured onto 
Actinomycetes Isolation Agar (AIA) medium and 
preserved in 20% glycerol stored at 4 oC until use.  
 
In vitro screening of isolates for anti-bacterial activity 
Morphologically distinct actinomycetes isolates 
were chosen for antibacterial and antifungal activity. 
The preliminary screening was made against the 
pathogenic test organisms using single line streak 
method22 on agar medium. Pure actinomycetes 
isolates were inoculated in a single streak and 
incubated at 28 oC for four days for the production of 
any antibiotics. A single streak of each test organism 
was added perpendicular to the actinomycetes streak. 
Test organisms were placed perpendicular to culture 
streak and the plates were incubated for 24 h at 37 oC. 
Further, confirmation of the selected strain was 
subjected to molecular taxonomic studies. 
 
Molecular identification 
The genomic DNA was isolated from the selected 
strain using the method of Hopwood21.  The DNA 
samples of the strain were amplified using a PCR kit 
(Synergy Scientific Services, Chennai, India) using 
consensus primers, the ~0.25 kb 16SrDNA fragment 
was amplified using high-fidelity PCR polymerase.  
The purified fragments were directly sequenced using 
Ampli Tag FS DNA sequencing kit (Applied Dio 
system).  Sequence of 1478bp was perforated with a 
model 377 PRISM automatic sequencer (Applied 
Biosystems).  The data were analyzed using applied 
biosystem DNA editing and assembly software and 
sequence comparisons were obtained using the Micro 
Seq Software. Sequence similarity search was made 
for the 16SrDNA sequence of the strain by applying 
its sequence to BLAST search of the NCBI (National 
Centre for Biotechnological Information, USA). The 
16SrDNA gene sequence of the strain was manually 
aligned21 with the sequences of species members of 
the same genus/family obtained from the GenBank 




The fermentation conditions were optimized for the 
strain and fermentation was carried in 500 ml 
Erlenmeyer flask. Initially, this strain was grown at  
28 oC in Starch Casein Agar (SCA) with the pH of  
7.5 for one week. Spores were collected and cultured 
with 10 ml of the same medium broth. Cultivation of 
the strain was made by transferring 1 ml (ca. 
108 cells/ml) of the spore suspension and incubated at 
28 °C and 250 rpm for seven days in 500 ml 
Erlenmeyer flasks containing 100 ml of antibiotic 
production medium with 2% sucrose, 0.25% yeast 
extract, 0.1% K2HPO4, 0.05% MgSO4.7H2O, 0.001% 
FeSO4.7H2O, 0.002% NaCl, pH 7.5 and made up to 
100% by using seawater. 
 
Extraction 
The crude culture broth of isolated strain was 
centrifuged at 10,000 rpm for 30 min at 4 °C by 
maintaining all the physico-chemical factors at 
optimum levels. Growth and antibiotic production 
were estimated at 30 oC, pH 7.5 and sodium chloride 
concentration of 2.0%. The total culture filtrate of the 
metabolites was used for solvent extraction using 
ethyl acetate in triplicate. The organic layer was 
collected and the solvent ethyl acetate was evaporated 
using vacuum rotary evaporator and lyophilized.  
 
Purification 
The crude antimicrobial compound (5mg) was 
chromatographed on silica gel (Merck, particle size 




0.100 - 0.200 mm) column (22X5 cm) and eluted with 
chloroform: ethyl acetate (70:30) to give 10 major 
fractions. The dried residues of all the 10 major fractions 
were dissolved separately in specified volume of ethyl 
acetate (1 mg/ml) concentration and tested for their 
antimicrobial activities against the pathogenic organisms 
by disc-diffusion method. All the extracts and fractions 
were subjected to thin layer chromatography on silica 
gel (60 F 254 MERCK; 25 TLC aluminum sheets 
20x20cm MERCK) and run in chloroform: ethyl acetate 
(70:30) to visualize the efficiency of separation of UV 
fluorescent substances. Each batch was repeated several 
times to confirm the results. 
 
Determination of antibiotic compound 
The purified antimicrobial compound with an Rf 
value of 0.43 was identified from ethyl acetate extract 
of the metabolites of isolated strain as reddish crystals 
with a melting point of 110-120 oC. 
 
Test organism 
The following test pathogenic organisms were used 
to test Minimum Inhibitory Concentration (MIC) of 
the extracts: bacterial strains such as Escherichia coli, 
Pseudomonas aeruginosa, Vibrio harveyi, Salmonella 
typhii and fungal such as Aspergillus niger, A. flavus, 
Candida albicans and Penicillium sp. were obtained 
from Raja Muthiah Medical College Hospital 
(RMMCH), Annamalai University, Tamil Nadu. 
 
Preparation of inoculums 
Inoculums of each bacterial strain was inoculated 
in 3 ml of Mueller Hinton Broth (MHB) and 
incubated at 37 °C for 24 h. After incubation period, 
the culture was diluted with sterile MHB to provide 
initial cell count of about 10-4 CFU/ml. The four 
pathogenic fungi were grown on Sabouraud Dextrose 
Agar (SDA) slants at 28 oC for 10 days and the spores 




Antimicrobial activity of MAB18 was assayed by 
disc diffusion method23. The pathogenic organisms 
were grown individually in the sterile nutrient broth 
for 24 hr at 37 °C in the case of bacteria and 28 °C for 
72 h in the case of fungi. For antimicrobial assay, 
Mueller Hinton Agar (MHA) for bacteria and 
Sabouraud Agar for fungi were prepared poured 
aseptically into petriplates and allowed for 
solidification. Then the test organisms grown in the 
nutrient broth were swabbed into the sterile MH agar 
plates using sterile cotton buds. Agar wells were 
prepared using sterile cork borer (diameter 4 mm). 
Subsequently, 100 µl of MAB18 of extracted 
supernatant was added into each well. Negative 
control was prepared using the respective solvent. To 
compare the antibacterial and antifungal activities, 
ampicillin (30 µg/disc) and nystatin (20 µg/disc) were 
used as a positive control. For each strain five 
replicates were made. The petridishes were incubated 
at 8-10 °C for 16 h for the diffusion of the bioactive 
compound. For each strain five replicates were made. 
The plates were incubated for 24 hours at 37 °C for 
bacterial growth. After incubation, the plates were 
examined for the antimicrobial activity and zones of 
inhibition were recorded in millimeters and all the 
data were statistically analyzed and mean and 
standard deviation were calculated. 
 
Determination of MIC 
The MIC was determined by using the method of 
National Committee for Clinical Laboratory 
Standards24. The required concentrations  
(1000 mg/ml, 500 mg/ml, 250 mg/ml, 125 mg/ml, 
62.5 mg/ml and 31.25 mg/ml) of extract MAB18 was 
dissolved in dimethyl sulfoxide (DMSO) (2%). These 
tests were made to find out the least concentration of 
MAB18 extracts that inhibit the growth of human 
pathogens. The test was carried out in 96 well 
microlititre plates, so that replicates of individual 
sample can be run. An inoculum of 5 ml from each 
well was inoculated. The antibacterial agent 
ampicillin and antifungal nystatin (20 µg/disc) were 
included in the assays as positive controls.  The plates 
were incubated for 72 h for fungi and 24 h for bacteria 
at 37 oC. The MIC for bacteria was determined as the 
lowest concentration of the compound inhibiting the 
visual growth of the test cultures on the agar plate. 
Three replications were maintained. 
 
Results 
A total of 42 strains of actinobacteria were isolated 
from five different marine stations. Of these  
42 isolates, the suspected 10 actinobacterial strains 
were isolated and inoculated on the Actinomycetes 
Isolation Agar medium for purification and pure 
colonies were maintained in the same agar slant at  
4 °C and were named MAB5, MAB8, MAB14, 
MAB18, MAB20, MAB25, MAB29, MAB33, 
MAB36 and MAB41. All the 10 culture strains were 
screened against bacterial and fungal pathogens as 
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shown in Table 1. In antimicrobial screening test, the 
strain MAB18 inhibits the growth of all the bacteria 
and fungi which was selected for further study. 
 
Molecular taxonomy (16S rDNA analysis) 
Identification of actinomycetes on the basis of 
morphological characteristics is not reliable for all 
groups of organisms, including actinomycetes which 
possess limited morphological differentiation25 and 
can be relied on the basis of biochemical tests and 
assimilation assays26. When compared to 
morphological and biochemical characterization 
methods, 16S rDNA analysis is found to be the novel 
and accurate method for identifying unknown species; 
16S rRNA sequencing appears to have the potential 
ability to differentiate strains at the species level.  
The 16S rDNA of the strain MAB18 was amplified 
through PCR which shows the molecular weight of 
0.5 kb corresponding to that of the 1000 bp DNA 
ladder in 1% agarose gel.  The amplified product was 
purified to remove the excess primer for sequencing 
and it was sequenced using the automated DNA 
sequencer. Sequence of the strain MAB18 showed 
partial 16S rDNA sequences, consisting of 1478 
nucleotides (Fig. 1), which was submitted to the 
GenBank (National Center for Biotechnology 
Table 1 —The antimicrobial activity of actinobacterial isolates against pathogenic bacteria and fungi (single steak method) 
Strain Name E. coli P. aeruginosa V.  harveyi S. typhi A. niger A. flavus C. albicans Penicillium sp. 
MAB 1 + + + + - - - - 
MAB5 + + + - - - - - 
MAB8 + + + + - - - - 
MAB14 + - + - + - + - 
MAB18 + + + + + + + + 
MAB20 + - - - - + - - 
MAB25 + - - - + - - - 
MAB29 + + + - + - - + 
MAB33 + + - + - - + - 
MAB36 + + + + + - + - 
MAB41 + + + + + - - - 
MAB5 + + + + - - + - 
 
 
Fig. 1 — 16S rDNA sequence of the strain MAB18 




Information, USA) and an Accession Number 
(JQ068140) was obtained for MAB18 strain. 
 
Antimicrobial activity 
Based on the preliminary screening results, 
MAB18 was taken to investigate the extraction 
evaluation of its antimicrobial property (Figs 1 and 2). 
Ethyl acetate was used as an extract for the recovery 
of antibiotics from strain MAB18 and purified by 
using chromatographic technique. Then it was tested 
against bacterial and fungal pathogens. The mean and 
standard deviation values are shown in Table 2. The 
highest zone of inhibition was observed against  
E. coli (8.2±0.8mm), P. aeroginosa (10.4±0.6 mm), 
Vibrio harveyi (7.2±0.8mm), S. typhi (10.6±-0.4 mm) 
for bacteria and A. niger (11.2±0.8 mm), and A. flavus 
(9.8±0.2 mm) C. albicans (10.4±0.6mm), and 
Penicillium sp (7.2±0.8mm), for fungi, whereas it was 
21.4±0.6 and 20.4±0.6 mm for the standard ampicillin 
and nystatin Fig.3. 
 
Minimum inhibitory concentration (MIC) 
The MIC values of ethyl acetate extract of MAB18 
are: E. coli (125 mg/ml) and P. aeruginosa (250 
mg/ml), Vibrio harveyi (62.5 mg/ml), Salmonella 
typhi (250 mg/ml), A. Niger (250 mg/ml), A. flavus 
(500 mg/ml), C. albicans (500 mg/ ml) and 
Penicillium sp. (1000 mg/ml) as shown in Table 3. 
 
 
Fig. 2 —The antimicrobial activity of MAB18 against bacterial pathogen 
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The appearance of pathogenic  microbes with 
increased resistance to established antibiotics provides 
a major incentive for the discovery of new 
antimicrobial agents24. However, investigation on 
isolation and identification of new bioactive 
compounds from marine microorganisms will be 
more effective in controlling diseases related to 
bacterial and fungal pathogens. Ability to produce a 
large  number of chemically different secondary 
metabolites is associated mostly with the 
actinomycetes. In particular, the genus  Streptomyces 
sp is widely reported for  the production of various 
antibiotics which are used therapeutically25. Yedir  
et al.26 showed that 21.88% of actinobacterial colonies 
 
 
Fig. 3 —The antimicrobial activity of MAB18 against fungal pathogen 
Table 2 —The antimicrobial activity (zone of inhibition) of 
MAB18 against pathogenic bacteria and fungi 
Pathogens Diameter of zone of inhibition (mm) 
Bacteria 
Escherichia coli 8.2±0.8 
Pseudomonas aeruginosa 10.4±0.6 
Vibrio  harveyi 7.2±0.8 
Salmonella typhi 10.6±-0.4 
Ampicillin  (30µg/disc) 21.4±0.6 
Fungi 
A. niger 11.2±0.8 
A. flavus 9.8±0.2 
C. albicans 10.4±0.6 
Penicillium sp. 7.2±0.8 
Nystatin (20µg/disc) 20.4±0.6 




isolated from  terrestrial environment had significant 
growth inhibitory activity against  pathogenic  fungal 
strains. Abo-Shadi et al.27 reported that the 
Streptomyces  sp. strain A 24S4  isolated from plant 
rhizosphere region at Al-Madinah  Al-Munawwarah, 
Saudi Arabia, exhibited 62.5% growth inhibitory 
activity against the clinically important fungal 
pathogens. 
In the present study, the suspected actinobacterial 
strains were isolated and inoculated in the AIA 
medium and preliminary screening test was made to 
identify the potential strain. The strain MAB18 
inhibits the growth of all the bacteria and fungi. The 
strain MAB18 was taken for further investigation for 
evaluation of its antimicrobial property. Ethyl acetate 
extracts of MAB18 was tested against bacteria and 
fungi pathogens. The strain Streptomyces  
sp. (MAB18) exhibits good antimicrobial activity 
against all bacterial as well as fungal pathogens. Sahin 
and Ugur30 reported in vitro antimicrobial activity of 
three isolates as Streptomyces antibioticus (MU106, 
MU107) and S. rimosus (MU114) against Gram-
positive and Gram-negative bacteria and yeasts. 
Dehnad et al.31 reported 12 Streptomyces sp. isolates 
with different ability to produce antibiotics. Heng  
et al.32 recorded Streptomyces sp. strain PM2 and 
PM4 as potential antifungal candidate to inhibit the 
growth of pathogenic fungi, Colletotrichum capsisi 
and Colletotrichum gloeosporioides isolated from 
chilli fruit. Annamalai et al.33, working on Alcaligens 
faecalis (AU01) isolated from seafood industry 
effluent produced an alkaline protease and reported 
that the enzyme inhibited the growth of fish 
pathogens, such as Flavobacterium sp., Pseudomonas 
fluorescens, Vibrio harveyi, Proteus sp. and Vibrio 
parahaemolyticus. Naikpatil and Rathod34 reported 
the antimicrobial and cytotoxic activity of 
Streptomyces sp.  (KR-5) and proved its medical 
applications. They observed that the extract of 
Streptomyces tanashiensis strain (A2D) showed 
antibiotic activity against Bacillus subtilis (15 mm), 
Staphylococcus aureus (25 mm), Escherichia coli  
(21 mm) and Klebsiella pneumonia (23 mm). 
Manivasagan et al.35 reported that the extract of 
Streptomyces sp. (PM-32) showed antibiotic activity 
against Bacillus subtilis (20 mm) and E.coli (16 mm). 
Ethyl acetate extract of MAB18 also showed 
inhibition against all the pathogenic fungi with the 
highest zone of inhibition against A. niger (11.2±0.8) 
and the least inhibition observed against Penicillium 
sp. (7.2±0.8 mm). In an earlier study, AL-Bari et al.36 
reported 13 mm (20 µg/disc) inhibition zone against 
A. flavus and Kavitha et al.37 reported the antifungal 
effect of Nocardia levis MK-VL_113 against 
Fusarium oxysporum. Manivasagan et al.35 reported 
that the extract of Streptomyces sp. PM-32 showed 
antibiotic activity against A. flavus. 
 
Conclusion 
The present investigation about the antagonistic 
activity of marine Streptomyces sp. exhibits very good 
inhibition activity against human pathogenic organisms. 
Hence, it has been concluded that sediments of 
Nagapattinam coast, Southeast coast of India possess 
antibiotic producing actinomycetes and may be tapped 
as one of the India’s potential source of novel 
antibiotics. They have every possibility to be used 
against both bacterial and fungal pathogenic organisms. 
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